Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Revolution Medicines’ Acquisition of EQRx
Francisco Partners and TPG’s $6.5 Billion Acquisition of New Relic
Davis Polk & Wardwell and Paul Hastings LLP are advising Francisco Partners and TPG, and Latham & Watkins LLP is advising New Relic on the transaction....
Silver Lake’s Investment in ProService
Latham & Watkins is representing Silver Lake in the transaction. ProService announced that Silver Lake, a global leader in technology investing, has partnered with the ProService...
Bionano Genomics’ Acquisition of Purigen Biosystems
Latham & Watkins LLP represented Purigen in the transaction. Bionano Genomics, Inc. (NASDAQ: BNGO) has entered into a definitive agreement to acquire Purigen Biosystems, Inc., a...